Intelligent Drug Discovery Market Size Worth USD 3,711.8 Million by 2027
The growing demand for cost-effective medicines and the adoption of cloud-based applications will drive the demand for intelligent drug discovery.
The global Intelligent Drug Discovery
Market is
forecasted to be worth USD 3,711.8 Million by 2027, according to a current
analysis by Emergen Research. The intelligent drug technology market is
growing, and several pharmaceutical companies are focusing on the development
of drugs using artificial intelligence. The pharma companies are taking
advantage of the technology to discover drugs for more complex diseases.
The growing adoption of cloud-based applications and the
expiration of patented drugs will pave the way for new generic and OTC
medicines, which will influence market demand. The advancement in deep learning
and machine learning will allow pharmaceutical companies to reorganize molecule
binding properties with high accuracy.
Market Size – USD 258.9 Million
in 2019, Market Growth - CAGR of 39.4%, Market trends –Advancement in
technology
Get a sample of the
report (To Understand the Complete Structure of this Report [Summary
+ TOC])@ https://www.emergenresearch.com/request-sample/356
Market Scope:
One of the report’s central
components is the Intelligent Drug Discovery market segmentation that includes
the product type gamut, application spectrum, end-user industry landscape,
significant geographical regions, and the top market contenders. The report
contains unbiased industry expert opinions on the current market scenario, past
market performance, production & consumption rates, demand & supply
ratio, and revenue generation forecasts over the estimated period. The key players’ financial positions, along with their
gross profits, sales volumes, sales revenue, manufacturing costs, and other
financial ratios, have been accurately gauged in the report. Furthermore,
several analytical tools like investment assessment, SWOT analysis, and
Porter’s Five Forces Analysis have been implemented by our analysts’ team to
evaluate the production and distribution capacities of the Intelligent Drug
Discovery market players.
Competitive Terrain:
The
Global Intelligent Drug Discovery Market is highly consolidated due to the
presence of a large number of companies across this industry. The report
discusses the current market standing of these companies, their past
performances, demand and supply graph, production and consumption patterns,
sales network, distribution channels, and growth opportunities in the market at
length. The report scrutinizes the strategic approach of key market players
towards expanding their product offerings and fortifying their market foothold.
The
leading market contenders listed in the report are as follows:
·
Key participants include IBM Corporation, Microsoft Corporation, Google,
NVIDIA Corporation, Cloud Pharmaceuticals, Inc., Atomwise, Inc., Insilico
Medicine, Exscientia, Bioage, and Envisagenics, among others.
For the purpose of this
report, Emergen Research has segmented into the global Intelligent Drug
Discovery Market on the offering, technology, application, end-user, and
region:
Offering
Outlook (Revenue, USD Billion; 2017-2027)
·
Software
·
Services
Technology
Outlook (Revenue, USD Billion; 2017-2027)
·
Machine Learning
1.
Supervised Learning
2.
Deep Learning
3.
Reinforcement Learning
4.
Unsupervised Learning
·
Other Technologies
Application
Outlook (Revenue, USD Billion; 2017-2027)
·
Neurodegenerative Diseases
·
Metabolic Diseases
·
Immuno-Oncology
·
Cardiovascular Disease
·
Others
End-User
Outlook (Revenue, USD Billion; 2017-2027)
·
Contract Research Organizations
·
Pharmaceutical & Biotechnology Companies
·
Research Centers and Academic & Government Institutes
Regional Analysis of the Market:
•North
America (U.S., Canada)
•Europe
(U.K., Italy, Germany, France, Rest of EU)
•Asia
Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
•Latin
America (Chile, Brazil, Argentina, Rest of Latin America)
•Middle
East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Some Key Highlights from the Report
·
In October 2020, Optibrium launched Cerella, an intelligence
platform for active learning in drug discovery. Cerella’s architecture combines
cloud computing with on-premises deployment offering both scalability and data
security.
·
The software segment held a larger market share, and factors
such as less cost and time, low rate of failure, a large number of software
developers for the discovery of drugs, and strong demand from big
pharmaceuticals are driving the segment’s demand.
·
Machine learning help in optimizing therapy by integrating
clinical and biomedical data with computational models. It is used to build
software for combinational therapies and testing drugs. Machine learning offers
a lucrative potential for drug discovery and personalized medicine.
Request a discount on the report@
https://www.emergenresearch.com/request-discount/356
The Intelligent Drug Discovery Market report also
includes an investment analysis and growth trend analysis to help readers
maximize their return on investment. It highlights the growth opportunities
existing in the global Intelligent Drug Discovery market segments. It offers an
extensive investigation of the import-export status and the rates of production
and consumption. The Intelligent Drug Discovery Market report also provides
some of the essential market aspects to draw a forecast for the coming years
based on the information derived as part of the historical analysis and an
analysis of the current market scenario.
Request
customization of the report@ https://www.emergenresearch.com/request-for-customization/356
Thank you for
reading our report. For further queries or to request customization, please get
in touch with us. Our team will ensure you get the report best suited for your
needs.
About
Us:
Emergen Research is a market research and consulting company that
provides syndicated research reports, customized research reports, and
consulting services. Our solutions purely focus on your purpose to locate,
target, and analyse consumer behaviour shifts across demographics, across
industries, and help clients make smarter business decisions. We offer market
intelligence studies ensuring relevant and fact-based research across multiple
industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.
We consistently update our research offerings to ensure our clients are aware
of the latest trends existent in the market. Emergen Research has a strong base
of experienced analysts from varied areas of expertise. Our industry experience
and ability to develop a concrete solution to any research problems provides
our clients with the ability to secure an edge over their respective
competitors.
Contact Us:
·
Eric
Lee
·
Corporate
Sales Specialist
·
Emergen Research | Web: www.emergenresearch.com
·
Direct
Line: +1 (604) 757-9756
·
E-mail: sales@emergenresearch.com
·
Visit for More Insights: https://www.emergenresearch.com/insights
·
Explore Our Custom Intelligence services | Growth Consulting Services
·
Read Full Press Release: https://www.emergenresearch.com/press-release/global-intelligent-drug-discovery-market

Comments
Post a Comment